We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current APTO market cap is 18.44M. The company's latest EPS is USD -5.5448 and P/E is -12.01.
| Quarter End | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.6M | -11.83M | -16.25M | -11.5M | -14.1M |
| Net Income | -5.51M | -11.53M | -16.23M | -11.48M | -13.68M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -29.11M | -26.86M | -55.77M | -65.45M | -42.6M |
| Net Income | -28.87M | -26.28M | -55.24M | -65.35M | -41.82M |
| Quarter End | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 19.72M | 92.56M | 115.2M | 72.6M | 39.33M |
| Total Liabilities | 4.3M | 5.32M | 5.79M | 7.32M | 13.34M |
| Total Equity | 15.42M | 87.24M | 109.41M | 65.28M | 25.99M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 16.87M | 100.48M | 126.26M | 82.53M | 51.03M |
| Total Liabilities | 2.79M | 6.55M | 7.35M | 8.29M | 13.29M |
| Total Equity | 14.08M | 93.93M | 118.92M | 74.24M | 37.74M |
| Quarter End | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.87M | -8.11M | -10.38M | -9.65M | -11.3M |
| Investing | -24k | -12.43M | -20.01M | 7.51M | -2.96M |
| Financing | 6.18M | 436k | 75k | 15k | 50k |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -23.21M | -21.56M | -33.89M | -43.3M | -32.32M |
| Investing | 12k | -17.37M | 12.63M | -35.21M | 30.07M |
| Financing | 27.87M | 103.45M | 58.81M | 226k | 116k |
| Market Cap | 18.44M |
| Price to Earnings Ratio | -12.01 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 13.59 |
| Price to Book Ratio | 13.31 |
| Dividend Yield | - |
| Shares Outstanding | 7.54M |
| Average Volume (1 week) | 54.8k |
| Average Volume (1 Month) | 38.99k |
| 52 Week Change | -76.38% |
| 52 Week High | 11.55 |
| 52 Week Low | 2.14 |
| Spread (Intraday) | 0.24 (9.34%) |
| Company Name | Aptose Biosciences Inc |
| Address |
5955 airport road mississauga, ontario L4V 1R9 |
| Website | https://www.aptose.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
